Login / Signup
Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's syndrome.
Liping Xu
Yan Zhang
Na Lin
Xinwei Song
Qiaoding Dai
Published in:
Science progress (2022)
Eltrombopag is effective and safe for patients with ITP associated with SS during corticosteroid withdrawal. Thus it may be a crucial therapeutic strategy for reducing corticosteroid-related side effects in SS patients with ITP.
Keyphrases
</>
case report
rheumatoid arthritis
drug induced